Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancer

the past hospitalization and its association with suicide attempts and ideation in patients with mdd and comparison with bmd (depressed type) group

چکیده ندارد.

PILOT OPEN LABEL STUDY TO EVALUATE INTRAVENOUS FERRIC CARBOXYMALTOSE (FERINJECT ®) IN PATIENTS WITH CKD (pre-dialysis) WITH ANEMIA TREATED WITH EPO AND ORAL IRON IN BUENOS AIRES-ARGENTINA

Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC

Introduction Increasing number of studies is now devoted to immunotherapy of cancer. We evaluated the clinical benefit of hepcortespenlisimut‐L (V5) – an oral therapeutic vaccine designated by the US FDA as an orphan drug for treatment of hepatocellular carcinoma (HCC). Patients Open-label Phase II trial (NCT02256514) is currently underway, which by now has enrolled 75 patients with advanced HC...

An open-label phase Ib dose-escalation study of TRC105 (anti-endoglin antibody) with bevacizumab in patients with advanced cancer.

PURPOSE Endoglin, an endothelial cell membrane receptor expressed on angiogenic tumor vessels, is essential for angiogenesis and upregulated in the setting of VEGF inhibition. TRC105 is an anti-endoglin IgG1 monoclonal antibody that potentiates VEGF inhibitors in preclinical models. This study assessed safety, pharmacokinetics, and antitumor activity of TRC105 in combination with bevacizumab. ...

evaluation of fat atrophy in patients with dermis fat graft of orbit by ct-scan

چکیده ندارد.